CON Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, NEC · NYSE · SEC CIK 2014596 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.8%
TTM net income YoY41.2%
TTM EPS YoY44.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin29.9%
Operating margin16.9%
Net margin9.3%
FCF margin11.0%
EBITDA margin20.3%
Returns
ROE48.5%
ROA7.4%
ROIC (approx.)15.6%
Asset turnover0.80x
Leverage & solvency
Liabilities / assets82.2%
Debt / equity3.00x
Current ratio1.30x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.51x
Accruals ratio-3.8%
Payout ratio14.8%
Capex / revenue3.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $622.12M | $606.03M | $569.55M | $539.08M | $572.80M | $550.78M | $500.75M | $465.04M |
| Cost of revenue | $426.65M | $413.93M | $399.09M | $398.35M | $405.54M | $389.33M | $357.10M | $344.85M |
| Gross profit | $195.47M | $192.10M | $170.47M | $140.73M | $167.26M | $161.45M | $143.65M | $120.19M |
| SG&A expense | $60.93M | $56.68M | $55.28M | $50.78M | $52.88M | $52.93M | $46.71M | $45.49M |
| Operating income | $115.20M | $115.07M | $95.61M | $69.66M | $94.47M | $89.54M | $80.32M | $59.09M |
| Interest expense | — | — | $26.00M | — | — | — | $25.55M | — |
| Pretax income | $90.04M | $89.34M | $69.61M | $42.79M | $65.79M | $61.35M | $53.90M | $32.65M |
| Income tax | $22.27M | $22.05M | $17.32M | $6.60M | $15.97M | $15.15M | $13.25M | $9.85M |
| Net income | $65.89M | $65.30M | $50.49M | $34.69M | $48.26M | $44.56M | $38.91M | $21.51M |
| EBITDA | $135.35M | $134.97M | $115.26M | $89.95M | $114.38M | $108.54M | $96.94M | $74.70M |
| EPS (basic) | 0.52 | 0.51 | 0.39 | — | 0.38 | 0.35 | 0.30 | — |
| EPS (diluted) | 0.52 | 0.51 | 0.39 | — | 0.38 | 0.35 | 0.30 | — |
| Dividends declared per share | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | — |
| Weighted avg. shares (diluted) | 127.10M | 127.79M | 128.49M | — | 128.17M | 128.17M | 128.15M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $85.82M | $158.04M | $61.70M | $79.90M | $49.94M | $73.87M | $52.11M | $183.25M |
| Receivables | $320.26M | $299.82M | $296.51M | $257.90M | $278.97M | $271.75M | $258.13M | $217.72M |
| Current assets | $459.66M | $506.48M | $404.21M | $383.10M | $375.44M | $395.17M | $351.59M | $437.21M |
| PP&E, net | $240.26M | $226.04M | $223.90M | $225.31M | $227.34M | $220.28M | $207.27M | $197.93M |
| Goodwill | $1.48B | $1.48B | $1.48B | $1.48B | $1.48B | $1.48B | $1.44B | $1.23B |
| Intangibles | — | — | — | $242.56M | — | — | — | $204.72M |
| Total assets | $3.01B | $3.01B | $2.89B | $2.86B | $2.84B | $2.84B | $2.73B | $2.52B |
| Current liabilities | $352.98M | $367.94M | $320.88M | $337.25M | $312.65M | $335.07M | $320.39M | $307.19M |
| Short-term debt | $11.60M | $12.41M | $13.66M | $10.74M | $11.92M | $13.92M | $15.76M | $10.09M |
| Long-term debt | $1.51B | $1.56B | $1.56B | $1.56B | $1.60B | $1.65B | $1.62B | $1.47B |
| Total debt | $1.52B | $1.57B | $1.58B | $1.57B | $1.61B | $1.67B | $1.63B | $1.48B |
| Total liabilities | $2.47B | $2.50B | $2.44B | $2.44B | $2.43B | $2.47B | $2.40B | $2.22B |
| Shareholders' equity | $506.98M | $477.10M | $424.71M | $393.28M | $385.49M | $342.64M | $307.12M | $275.67M |
| Net debt | $1.44B | $1.42B | $1.51B | $1.49B | $1.56B | $1.59B | $1.58B | $1.30B |
| Shares outstanding | 126.52M | 127.52M | 127.96M | 128.63M | 128.17M | 128.17M | 128.17M | 128.13M |
| Cash flow statement | ||||||||
| Operating cash flow | $51.87M | $135.21M | $21.02M | $118.69M | $60.63M | $88.38M | $11.70M | $93.71M |
| Capital expenditure | $22.47M | $15.66M | $11.09M | $20.17M | $21.21M | $25.23M | $15.73M | $16.69M |
| Free cash flow | $29.40M | $119.55M | $9.93M | $98.52M | $39.42M | $63.15M | -$4.03M | $77.03M |
| Investing cash flow | -$25.88M | -$14.20M | -$14.85M | -$20.13M | -$20.47M | -$79.51M | -$294.75M | -$16.69M |
| Financing cash flow | -$98.21M | -$24.67M | -$24.37M | -$68.60M | -$64.09M | $12.89M | $151.90M | -$30.59M |
| Depreciation & amortization | $20.15M | $19.90M | $19.65M | $20.29M | $19.91M | $19.00M | $16.62M | $15.61M |
| Stock-based compensation | $4.55M | $4.13M | $4.13M | $3.61M | $2.33M | $2.29M | $2.27M | $1.83M |
| Dividends paid | $8.00M | $8.00M | $8.00M | $8.00M | $8.00M | $16.02M | $0 | $7.96M |
Free plan shows the latest 8 periods; Pro shows all 15 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.